Whitebox Advisors’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-62,500
Closed -$3.5K 417
2023
Q3
$3.5K Hold
62,500
﹤0.01% 280
2023
Q2
$9.21K Hold
62,500
﹤0.01% 240
2023
Q1
$5.94K Hold
62,500
﹤0.01% 399
2022
Q4
$6.24K Hold
62,500
﹤0.01% 541
2022
Q3
$5K Hold
62,500
﹤0.01% 737
2022
Q2
$9K Hold
62,500
﹤0.01% 681
2022
Q1
$14K Buy
+62,500
New +$16.2K ﹤0.01% 761

Whitebox Advisors's BIOSW Position: Q4 2023 in Review

Whitebox Advisors sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 62,500 shares — an estimated $3.5K sold.

Whitebox Advisors first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $14K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

  • Whitebox Advisors reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • Whitebox Advisors sold 62,500 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $3.5K.
  • Whitebox Advisors first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
  • Whitebox Advisors's BioPlus Acquisition Corp. Warrants position peaked at $14K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Whitebox Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.